| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
CHRNB2 Lentiviral Vector (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
| Short name: |
CHRNB2 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
b 2 (neuronal) Lentiviral integrating Desoxyribonucleic acid sequence (H, nicotinic, sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Red Fluorescent-2A-Puro), cholinergic receptor |
| Alternative to gene target: |
CHRNB2 and IDBG-102965 and ENSG00000160716 and 1141, CHRNB2 and IDBG-632434 and ENSBTAG00000007517 and 517519, Cell surfaces, Chrnb2 and IDBG-164981 and ENSMUSG00000027950 and 11444, EFNL3 and nAChRB2, REM sleep and biological process this GO :0042391 and regulation of membrane potential and biological process this GO :0045188 and regulation of circadian sleep/wake cycle, beta 2 (neuronal), cholinergic and biological process this GO :0007601 and visual perception and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0007612 and learning and biological process this GO :0007613 and memory and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008144 and drug binding and molecular function this GO :0008306 and associative learning and biological process this GO :0008542 and visual learning and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0014059 and regulation of dopamine secretion and biological process this GO :0015276 and ligand-gated ion channel activity and molecular function this GO :0015464 and acetylcholine receptor activity and molecular function this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019233 and sensory perception of pain and biological process this GO :0021562 and vestibulocochlear nerve development and biological process this GO :0021631 and optic nerve morphogenesis and biological process this GO :0021771 and lateral geniculate nucleus development and biological process this GO :0021952 and central nervous system projection neuron axonogenesis and biological process this GO :0021955 and central nervous system neuron axonogenesis and biological process this GO :0030054 and cell junction and cellular component this GO :0030890 and positive regulation of B cell proliferation and biological process this GO :0032225 and regulation of synaptic transmission, dopaminergic and biological process this GO :0032226 and positive regulation of synaptic transmission, dopaminergic and biological process this GO :0033603 and positive regulation of dopamine secretion and biological process this GO :0034220 and ion transmembrane transport and biological process this GO :0035094 and response to nicotine and biological process this GO :0035095 and behavioral response to nicotine and biological process this GO :0035176 and social behavior and biological process this GO :0042053 and regulation of dopamine metabolic process and biological process this GO :0042113 and B cell activation and biological process this GO :0042166 and acetylcholine binding and molecular function this GO :0042220 and response to cocaine and biological process this GO :0042320 and regulation of circadian sleep/wake cycle, nicotinic, non-REM sleep and biological process this GO :0045211 and postsynaptic membrane and cellular component this GO :0045471 and response to ethanol and biological process this GO :0045759 and negative regulation of action potential and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048814 and regulation of dendrite morphogenesis and biological process this GO :0050877 and neurological system process and biological process this GO :0050890 and cognition and biological process this GO :0051291 and protein heterooli this GO merization and biological process this GO :0051899 and membrane depolarization and biological process this GO :0051963 and regulation of synapse assembly and biological process this GO :0060084 and synaptic transmission involved in micturition and biological process, protein heterodimerization activity, this GO :0001508 and action potential and biological process this GO :0001661 and conditioned taste aversion and biological process this GO :0001666 and response to hypoxia and biological process this GO :0004889 and acetylcholine-activated cation-selective channel activity and molecular function this GO :0005230 and extracellular ligand-gated ion channel activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005892 and acetylcholine-gated channel complex and cellular component this GO :0006810 and transport and biological process this GO :0006811 and ion transport and biological process this GO :0006816 and calcium ion transport and biological process this GO :0006939 and smooth muscle contraction and biological process this GO :0007165 and signal transduction and biological process this GO :0007268 and synaptic transmission and biological process this GO :0007271 and synaptic transmission, this GO :0004889 : acetylcholine-activated cation-selective channel activity, this GO :0004889 : acetylcholine-activated cation-selective channel activity and also this GO :0005230 : extracellular ligand-gated ion channel activity and also this GO :0005515 : protein binding and also this GO :0008144 : drug binding and also this GO :0015276 : ligand-gated ion channel activity and also this GO :0015464 : acetylcholine receptor activity and also this GO :0042166 : acetylcholine binding and also this GO :0046982 : protein heterodimerization activity, this GO :0005230 : extracellular ligand-gated ion channel activity, this GO :0005515 : protein binding, this GO :0008144 : drug binding, this GO :0015276 : ligand-gated ion channel activity, this GO :0015464 : acetylcholine receptor activity, this GO :0042166 : acetylcholine binding, this GO :0046982 : protein heterodimerization activity, cholinergic receptor |
| Identity: |
1962 |
| Gene: |
CHRNB2 |
More about : CHRNB2 |
| Long gene name: |
cholinergic receptor nicotinic beta 2 subunit |
| Synonyms gene name: |
beta 2 (neuronal) cholinergic receptor, beta polypeptide 2 (neuronal) cholinergic receptor, cholinergic receptor, nicotinic, nicotinic, nicotinic beta 2 |
| Synonyms name: |
acetylcholine receptor, beta 2 (neuronal) , nicotinic |
| Locus: |
1q21, 3 |
| Discovery year: |
1990-05-11 |
| GenBank acession: |
U62437 |
| Entrez gene record: |
1141 |
| Pubmed identfication: |
1505988 |
| RefSeq identity: |
NM_000748 |
| Classification: |
Cholinergic receptors nicotinic subunits |
| Havana BLAST/BLAT: |
OTTHUMG00000037262 |